Oxford Asset Management buys $14,885,290 stake in PAREXEL International Corporation (PRXL)

PAREXEL International Corporation (PRXL) : Oxford Asset Management scooped up 64,718 additional shares in PAREXEL International Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 214,919 shares of PAREXEL International Corporation which is valued at $14,885,290.PAREXEL International Corporation makes up approximately 0.59% of Oxford Asset Management’s portfolio.

Other Hedge Funds, Including , Royce Associates Lp reduced its stake in PRXL by selling 7,200 shares or 2.39% in the most recent quarter. The Hedge Fund company now holds 293,600 shares of PRXL which is valued at $20,334,736. PAREXEL International Corporation makes up approx 0.13% of Royce Associates Lp’s portfolio.Fortaleza Asset Management Inc reduced its stake in PRXL by selling 1,130 shares or 33.14% in the most recent quarter. The Hedge Fund company now holds 2,280 shares of PRXL which is valued at $157,343. PAREXEL International Corporation makes up approx 0.12% of Fortaleza Asset Management Inc’s portfolio.Quantbot Technologies Lp boosted its stake in PRXL in the latest quarter, The investment management firm added 1,411 additional shares and now holds a total of 1,630 shares of PAREXEL International Corporation which is valued at $108,102. PAREXEL International Corporation makes up approx 0.01% of Quantbot Technologies Lp’s portfolio.Emerald Advisers Incpa reduced its stake in PRXL by selling 1,890 shares or 1.84% in the most recent quarter. The Hedge Fund company now holds 100,649 shares of PRXL which is valued at $6,728,386. PAREXEL International Corporation makes up approx 0.31% of Emerald Advisers Incpa’s portfolio.Boston Advisors boosted its stake in PRXL in the latest quarter, The investment management firm added 14,711 additional shares and now holds a total of 61,367 shares of PAREXEL International Corporation which is valued at $4,020,152. PAREXEL International Corporation makes up approx 0.10% of Boston Advisors’s portfolio.

PAREXEL International Corporation opened for trading at $70 and hit $70.545 on the upside on Monday, eventually ending the session at $70.09, with a gain of 0.76% or 0.53 points. The heightened volatility saw the trading volume jump to 3,16,152 shares. Company has a market cap of $3,707 M.

On the company’s financial health, PAREXEL International Corporation reported $0.94 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.93. The company had revenue of $538.60 million for the quarter, compared to analysts expectations of $532.59 million. The company’s revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.

Many Wall Street Analysts have commented on PAREXEL International Corporation. Credit Suisse Initiated PAREXEL International Corporation on Jun 21, 2016 to “Outperform”, Price Target of the shares are set at $75.

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company which provides a range of expertise in clinical research clinical logistics medical communications consulting commercialization and advanced technology products and services to the pharmaceutical biotechnology and medical device industries across the world. The Company operates through three segments: Clinical Research Services PAREXEL Consulting Services and PAREXEL Informatics. Its product and service offerings include clinical trials management data management epidemiology health economics/outcomes research pharmacovigilance medical communications clinical pharmacology patient recruitment clinical supply and drug logistics post-marketing surveillance medical imaging services electronic data capture systems clinical trial management systems Web-based portals and other product development tools and services.

Leave a Reply

PAREXEL International Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on PAREXEL International Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.